ACTRN12605000211662
Completed
Phase 2
Intravitreal triamcinolone injection for treatment of clinically significant diabetic macular oedema that persists after laser treatment
Professor Mark Gillies0 sites70 target enrollmentAugust 25, 2005
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Diabetic Macular Oedema
- Sponsor
- Professor Mark Gillies
- Enrollment
- 70
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Clinically significant diabetic macular oedema involving the fovea in one or both eyes (phakic and/or pseudophakic) which persists at least 3 months after adequate macular photocoagulation. Best corrected visual acuity in the affected eye(s) 6/9 or worse.
Exclusion Criteria
- •Glaucoma which is uncontrolled or is controlled but with glaucomatous visual field defects. Loss of vision due to other causes (e.g. age related macular degeneration, myopic macular degeneration). Significant macular ischemia (FFA). No useful vision in fellow eye. Known allergies to triamcinolone acetate or steroids. Patient is already under systemic treatment with \> 5mg prednisolone (or equivalent) daily. Intercurrent severe disease such as septicaemia. Any condition which would affect follow\-up or photographic documentation (e.g. geographical, psycho\-social, media opacities).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
The Use of Intravitreal Injection of Triamcinolone Acetonide in Diabetic Patients to Reduce Diabetic Macular EdemaDiabetic macular edemaEye - Diseases / disorders of the eyeACTRN12613000249752suez canal university hospital19
Completed
Not Applicable
Intravitreal Injection of Triamcinolone Acetonide in RetinitisIRCT201104266293N1Tehran University of Medical Sciences161
Active, not recruiting
Not Applicable
Triamcinolone Acetonide Intravitreal Injection for the treatment for exudative maculopathy - NDexudative maculopathyMedDRA version: 8.1Level: LLTClassification code 10038862Term: Retinal exudatesEUCTR2006-001727-19-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Completed
Not Applicable
Intravitreal Triamcinolone with Transpupillary Thermal Therapy (TTT) for Subfoveal Choroidal Neovascularization in Age Related Macular DegeneratioAge-Related Macular Degeneration (ARMD) not available for current therapiesEye DiseasesAge-Related Macular Degeneration (ARMD)ISRCTN74123635Association to Avoid Blindness (Asociación Para Evitar La Ceguera) (APEC) (Mexico)200
Completed
Not Applicable
Intravitreal triamcinolone acetonide combined withccataract surgery for diabetic macular edemadiabetic macular edemaJPRN-UMIN000029818Department of Ophthalmology, Mie University Graduate School of Medicine30